We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Gadolinium Claim Time-Barred By Plaintiff’s Admission To FDA Committee

Mealey's (June 5, 2019, 8:58 AM EDT) -- CLEVELAND — An Ohio federal judge on May 15 dismissed a woman’s gadolinium contrast agent injury lawsuit as time-barred after defendant Bayer Healthcare Pharmaceuticals Inc. turned up the plaintiff’s public testimony...
To view the full article, register now.